National Academies Press: OpenBook

Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment (2002)

Chapter: Appendix C Possible Combinations of Scores

« Previous: Appendix B Existing Frameworks of Systems for Evaluating the Safety of Other Substances
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Appendix C
Possible Combinations of Scores

There are 625 possible combinations of scores that fall under Priority Groups I through V. These are all listed below, in the priority order that would be indicated by the proposed framework. As described in Chapter 5, high prevalence of use would shift supplements to the highest priority within each Priority Group. NAD=no appropriate data.

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

I

3

3

3

3

 

3

3

3

2

 

3

3

3

NAD

 

3

3

3

1

 

3

3

3

0

 

3

3

2

3

 

3

3

NAD

3

 

3

3

1

3

 

3

3

0

3

 

3

3

2

2

 

3

3

2

NAD

 

3

3

2

1

 

3

3

2

0

 

3

3

NAD

2

 

3

3

NAD

NAD

 

3

3

NAD

1

 

3

3

NAD

0

 

3

3

1

2

 

3

3

1

NAD

 

3

3

1

1

 

3

3

1

0

 

3

3

0

2

 

3

3

0

NAD

 

3

3

0

1

 

3

3

0

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

II

3

2

3

3

 

3

NAD

3

3

 

3

1

3

3

 

3

0

3

3

 

3

2

3

2

 

3

2

3

NAD

 

3

2

3

1

 

3

2

3

0

 

3

2

2

3

 

3

2

NAD

3

 

3

2

1

3

 

3

2

0

3

 

3

NAD

3

2

 

3

NAD

3

NAD

 

3

NAD

3

1

 

3

NAD

3

0

 

3

NAD

2

3

 

3

NAD

NAD

3

 

3

NAD

1

3

 

3

NAD

0

3

 

3

1

3

2

 

3

1

3

NAD

 

3

1

3

1

 

3

1

3

0

 

3

1

2

3

 

3

1

NAD

3

 

3

1

1

3

 

3

1

0

3

 

3

0

3

2

 

3

0

3

NAD

 

3

0

3

1

 

3

0

3

0

 

3

0

2

3

 

3

0

NAD

3

 

3

0

1

3

 

3

0

0

3

 

3

2

2

2

 

3

2

2

NAD

 

3

2

2

1

 

3

2

2

0

 

3

2

NAD

2

 

3

2

NAD

NAD

 

3

2

NAD

1

 

3

2

NAD

0

 

3

2

1

2

 

3

2

1

NAD

 

3

2

1

1

 

3

2

1

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

II

3

2

0

2

 

3

2

0

NAD

 

3

2

0

1

 

3

2

0

0

 

3

NAD

2

2

 

3

NAD

2

NAD

 

3

NAD

2

1

 

3

NAD

2

0

 

3

NAD

NAD

2

 

3

NAD

NAD

NAD

 

3

NAD

NAD

1

 

3

NAD

NAD

0

 

3

NAD

1

2

 

3

NAD

1

NAD

 

3

NAD

1

1

 

3

NAD

1

0

 

3

NAD

0

2

 

3

NAD

0

NAD

 

3

NAD

0

1

 

3

NAD

0

0

 

3

1

2

2

 

3

1

2

NAD

 

3

1

2

1

 

3

1

2

0

 

3

1

NAD

2

 

3

1

NAD

NAD

 

3

1

NAD

1

 

3

1

NAD

0

 

3

1

1

2

 

3

1

1

NAD

 

3

1

1

1

 

3

1

1

0

 

3

1

0

2

 

3

1

0

NAD

 

3

1

0

1

 

3

1

0

0

 

3

0

2

2

 

3

0

2

NAD

 

3

0

2

1

 

3

0

2

0

 

3

0

NAD

2

 

3

0

NAD

NAD

 

3

0

NAD

1

 

3

0

NAD

0

 

3

0

1

2

 

3

0

1

NAD

 

3

0

1

1

 

3

0

1

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

II

3

0

0

2

 

3

0

0

NAD

 

3

0

0

1

 

3

0

0

0

III

NAD

3

3

3

 

2

3

3

3

 

1

3

3

3

 

0

3

3

3

 

NAD

3

3

2

 

NAD

3

3

NAD

 

NAD

3

3

1

 

NAD

3

3

0

 

NAD

3

2

3

 

NAD

3

NAD

3

 

NAD

3

1

3

 

NAD

3

0

3

 

2

3

3

2

 

2

3

3

NAD

 

2

3

3

1

 

2

3

3

0

 

2

3

2

3

 

2

3

NAD

3

 

2

3

1

3

 

2

3

0

3

 

1

3

3

2

 

1

3

3

NAD

 

1

3

3

1

 

1

3

3

0

 

1

3

2

3

 

1

3

NAD

3

 

1

3

1

3

 

1

3

0

3

 

0

3

3

2

 

0

3

3

NAD

 

0

3

3

1

 

0

3

3

0

 

0

3

2

3

 

0

3

NAD

3

 

0

3

1

3

 

0

3

0

3

 

NAD

3

2

2

 

NAD

3

2

NAD

 

NAD

3

2

1

 

NAD

3

2

0

 

NAD

3

NAD

2

 

NAD

3

NAD

NAD

 

NAD

3

NAD

1

 

NAD

3

NAD

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

III

NAD

3

1

2

 

NAD

3

1

NAD

 

NAD

3

1

1

 

NAD

3

1

0

 

NAD

3

0

2

 

NAD

3

0

NAD

 

NAD

3

0

1

 

NAD

3

0

0

 

2

3

2

2

 

2

3

2

NAD

 

2

3

2

1

 

2

3

2

0

 

2

3

NAD

2

 

2

3

NAD

NAD

 

2

3

NAD

1

 

2

3

NAD

0

 

2

3

1

2

 

2

3

1

NAD

 

2

3

1

1

 

2

3

1

0

 

2

3

0

2

 

2

3

0

NAD

 

2

3

0

1

 

2

3

0

0

 

1

3

2

2

 

1

3

2

NAD

 

1

3

2

1

 

1

3

2

0

 

1

3

NAD

2

 

1

3

NAD

NAD

 

1

3

NAD

1

 

1

3

NAD

0

 

1

3

1

2

 

1

3

1

NAD

 

1

3

1

1

 

1

3

1

0

 

1

3

0

2

 

1

3

0

NAD

 

1

3

0

1

 

1

3

0

0

 

0

3

2

2

 

0

3

2

NAD

 

0

3

2

1

 

0

3

2

0

 

0

3

NAD

2

 

0

3

NAD

NAD

 

0

3

NAD

1

 

0

3

NAD

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

III

0

3

1

2

 

0

3

1

NAD

 

0

3

1

1

 

0

3

1

0

 

0

3

0

2

 

0

3

0

NAD

 

0

3

0

1

 

0

3

0

0

IV

NAD

2

3

3

 

NAD

NAD

3

3

 

NAD

1

3

3

 

NAD

0

3

3

 

2

2

3

3

 

2

NAD

3

3

 

2

1

3

3

 

2

0

3

3

 

1

2

3

3

 

1

NAD

3

3

 

1

1

3

3

 

1

0

3

3

 

0

2

3

3

 

0

NAD

3

3

 

0

1

3

3

 

0

0

3

3

 

NAD

2

3

2

 

NAD

2

3

NAD

 

NAD

2

3

1

 

NAD

2

3

0

 

NAD

NAD

3

2

 

NAD

NAD

3

NAD

 

NAD

NAD

3

1

 

NAD

NAD

3

0

 

NAD

1

3

2

 

NAD

1

3

NAD

 

NAD

1

3

1

 

NAD

1

3

0

 

NAD

0

3

2

 

NAD

0

3

NAD

 

NAD

0

3

1

 

NAD

0

3

0

 

2

2

3

2

 

2

2

3

NAD

 

2

2

3

1

 

2

2

3

0

 

2

2

2

3

 

2

2

NAD

3

 

2

2

1

3

 

2

2

0

3

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

IV

2

NAD

3

2

 

2

NAD

3

NAD

 

2

NAD

3

1

 

2

NAD

3

0

 

2

NAD

2

3

 

2

NAD

NAD

3

 

2

NAD

1

3

 

2

NAD

0

3

 

2

1

3

2

 

2

1

3

NAD

 

2

1

3

1

 

2

1

3

0

 

2

1

2

3

 

2

1

NAD

3

 

2

1

1

3

 

2

1

0

3

 

2

0

3

2

 

2

0

3

NAD

 

2

0

3

1

 

2

0

3

0

 

2

0

2

3

 

2

0

NAD

3

 

2

0

1

3

 

2

0

0

3

 

NAD

2

2

3

 

NAD

2

NAD

3

 

NAD

2

1

3

 

NAD

2

0

3

 

NAD

NAD

2

3

 

NAD

NAD

NAD

3

 

NAD

NAD

1

3

 

NAD

NAD

0

3

 

NAD

1

2

3

 

NAD

1

NAD

3

 

NAD

1

1

3

 

NAD

1

0

3

 

NAD

0

2

3

 

NAD

0

NAD

3

 

NAD

0

1

3

 

NAD

0

0

3

 

1

2

3

2

 

1

2

3

NAD

 

1

2

3

1

 

1

2

3

0

 

1

2

2

3

 

1

2

NAD

3

 

1

2

1

3

 

1

2

0

3

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

IV

1

NAD

3

2

 

1

NAD

3

NAD

 

1

NAD

3

1

 

1

NAD

3

0

 

1

NAD

2

3

 

1

NAD

NAD

3

 

1

NAD

1

3

 

1

NAD

0

3

 

1

1

3

2

 

1

1

3

NAD

 

1

1

3

1

 

1

1

3

0

 

1

1

2

3

 

1

1

NAD

3

 

1

1

1

3

 

1

1

0

3

 

1

0

3

2

 

1

0

3

NAD

 

1

0

3

1

 

1

0

3

0

 

1

0

2

3

 

1

0

NAD

3

 

1

0

1

3

 

1

0

0

3

 

0

2

3

2

 

0

2

3

NAD

 

0

2

3

1

 

0

2

3

0

 

0

2

2

3

 

0

2

NAD

3

 

0

2

1

3

 

0

2

0

3

 

0

NAD

3

2

 

0

NAD

3

NAD

 

0

NAD

3

1

 

0

NAD

3

0

 

0

NAD

2

3

 

0

NAD

NAD

3

 

0

NAD

1

3

 

0

NAD

0

3

 

0

1

3

2

 

0

1

3

NAD

 

0

1

3

1

 

0

1

3

0

 

0

1

2

3

 

0

1

NAD

3

 

0

1

1

3

 

0

1

0

3

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

IV

0

0

3

2

 

0

0

3

NAD

 

0

0

3

1

 

0

0

3

0

 

0

0

2

3

 

0

0

NAD

3

 

0

0

1

3

 

0

0

0

3

V

2

2

2

2

 

2

2

2

NAD

 

2

2

2

1

 

2

2

2

0

 

2

2

NAD

2

 

2

2

NAD

NAD

 

2

2

NAD

1

 

2

2

NAD

0

 

2

2

1

2

 

2

2

1

NAD

 

2

2

1

1

 

2

2

1

0

 

2

2

0

2

 

2

2

0

NAD

 

2

2

0

1

 

2

2

0

0

 

2

NAD

2

2

 

2

NAD

2

NAD

 

2

NAD

2

1

 

2

NAD

2

0

 

2

NAD

NAD

2

 

2

NAD

NAD

NAD

 

2

NAD

NAD

1

 

2

NAD

NAD

0

 

2

NAD

1

2

 

2

NAD

1

NAD

 

2

NAD

1

1

 

2

NAD

1

0

 

2

NAD

0

2

 

2

NAD

0

NAD

 

2

NAD

0

1

 

2

NAD

0

0

 

2

1

2

2

 

2

1

2

NAD

 

2

1

2

1

 

2

1

2

0

 

2

1

NAD

2

 

2

1

NAD

NAD

 

2

1

NAD

1

 

2

1

NAD

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

V

2

1

1

2

 

2

1

1

NAD

 

2

1

1

1

 

2

1

1

0

 

2

1

0

2

 

2

1

0

NAD

 

2

1

0

1

 

2

1

0

0

 

2

0

2

2

 

2

0

2

NAD

 

2

0

2

1

 

2

0

2

0

 

2

0

NAD

2

 

2

0

NAD

NAD

 

2

0

NAD

1

 

2

0

NAD

0

 

2

0

1

2

 

2

0

1

NAD

 

2

0

1

1

 

2

0

1

0

 

2

0

0

2

 

2

0

0

NAD

 

2

0

0

1

 

NAD

2

2

2

 

NAD

2

2

NAD

 

NAD

2

2

1

 

NAD

2

2

0

 

NAD

2

NAD

2

 

NAD

2

NAD

NAD

 

NAD

2

NAD

1

 

NAD

2

NAD

0

 

NAD

2

1

2

 

NAD

2

1

NAD

 

NAD

2

1

1

 

NAD

2

1

0

 

NAD

2

0

2

 

NAD

2

0

NAD

 

NAD

2

0

1

 

NAD

2

0

0

 

NAD

NAD

2

2

 

NAD

NAD

2

NAD

 

NAD

NAD

2

1

 

NAD

NAD

2

0

 

NAD

NAD

NAD

2

 

NAD

NAD

NAD

NAD

 

NAD

NAD

NAD

1

 

NAD

NAD

NAD

0

 

NAD

NAD

1

2

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

V

NAD

NAD

1

NAD

 

NAD

NAD

1

1

 

NAD

NAD

1

0

 

NAD

NAD

0

2

 

NAD

NAD

0

NAD

 

NAD

NAD

0

1

 

NAD

NAD

0

0

 

NAD

1

2

2

 

NAD

1

2

NAD

 

NAD

1

2

1

 

NAD

1

2

0

 

NAD

1

NAD

2

 

NAD

1

NAD

NAD

 

NAD

1

NAD

1

 

NAD

1

NAD

0

 

NAD

1

1

2

 

NAD

1

1

NAD

 

NAD

1

1

1

 

NAD

1

1

0

 

NAD

1

0

2

 

NAD

1

0

NAD

 

NAD

1

0

1

 

NAD

1

0

0

 

NAD

0

2

2

 

NAD

0

2

NAD

 

NAD

0

2

1

 

NAD

0

2

0

 

NAD

0

NAD

2

 

NAD

0

NAD

NAD

 

NAD

0

NAD

1

 

NAD

0

NAD

0

 

NAD

0

1

2

 

NAD

0

1

NAD

 

NAD

0

1

1

 

NAD

0

1

0

 

NAD

0

0

2

 

NAD

0

0

NAD

 

NAD

0

0

1

 

NAD

0

0

0

 

1

2

2

2

 

1

2

2

NAD

 

1

2

2

1

 

1

2

2

0

 

1

2

NAD

2

 

1

2

NAD

NAD

 

1

2

NAD

1

 

1

2

NAD

0

 

1

2

1

2

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

V

1

2

1

NAD

 

1

2

1

1

 

1

2

1

0

 

1

2

0

2

 

1

2

0

NAD

 

1

2

0

1

 

1

2

0

0

 

1

NAD

2

2

 

1

NAD

2

NAD

 

1

NAD

2

1

 

1

NAD

2

0

 

1

NAD

NAD

2

 

1

NAD

NAD

NAD

 

1

NAD

NAD

1

 

1

NAD

NAD

0

 

1

NAD

1

2

 

1

NAD

1

NAD

 

1

NAD

1

1

 

1

NAD

1

0

 

1

NAD

0

2

 

1

NAD

0

NAD

 

1

NAD

0

1

 

1

NAD

0

0

 

1

1

2

2

 

1

1

2

NAD

 

1

1

2

1

 

1

1

2

0

 

1

1

NAD

2

 

1

1

NAD

NAD

 

1

1

NAD

1

 

1

1

NAD

0

 

1

1

1

2

 

1

1

1

NAD

 

1

1

1

1

 

1

1

1

0

 

1

1

0

2

 

1

1

0

NAD

 

1

1

0

1

 

1

1

0

0

 

1

0

2

2

 

1

0

2

NAD

 

1

0

2

1

 

1

0

2

0

 

1

0

NAD

2

 

1

0

NAD

NAD

 

1

0

NAD

1

 

1

0

NAD

0

 

1

0

1

2

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

V

1

0

1

NAD

 

1

0

1

1

 

1

0

1

0

 

1

0

0

2

 

1

0

0

NAD

 

1

0

0

1

 

1

0

0

0

 

1

0

0

0

 

0

2

2

2

 

0

2

2

NAD

 

0

2

2

1

 

0

2

2

0

 

0

2

NAD

2

 

0

2

NAD

NAD

 

0

2

NAD

1

 

0

2

NAD

0

 

0

2

1

2

 

0

2

1

NAD

 

0

2

1

1

 

0

2

1

0

 

0

2

0

2

 

0

2

0

NAD

 

0

2

0

1

 

0

2

0

0

 

0

NAD

2

2

 

0

NAD

2

NAD

 

0

NAD

2

1

 

0

NAD

2

0

 

0

NAD

NAD

2

 

0

NAD

NAD

NAD

 

0

NAD

NAD

1

 

0

NAD

NAD

0

 

0

NAD

1

2

 

0

NAD

1

NAD

 

0

NAD

1

1

 

0

NAD

1

0

 

0

NAD

0

2

 

0

NAD

0

NAD

 

0

NAD

0

1

 

0

NAD

0

0

 

0

1

2

2

 

0

1

2

NAD

 

0

1

2

1

 

0

1

2

0

 

0

1

NAD

2

 

0

1

NAD

NAD

 

0

1

NAD

1

 

0

1

NAD

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×

Priority Group

Human Data

Animal Data

Structure Data

In Vitro Data

V

0

1

1

2

 

0

1

1

NAD

 

0

1

1

1

 

0

1

1

0

 

0

1

0

2

 

0

1

0

NAD

 

0

1

0

1

 

0

1

0

0

 

0

0

2

2

 

0

0

2

NAD

 

0

0

2

1

 

0

0

2

0

 

0

0

NAD

2

 

0

0

NAD

NAD

 

0

0

NAD

1

 

0

0

NAD

0

 

0

0

1

2

 

0

0

1

NAD

 

0

0

1

1

 

0

0

1

0

 

0

0

0

2

 

0

0

0

NAD

 

0

0

0

1

 

0

0

0

0

Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 124
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 125
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 126
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 127
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 128
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 129
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 130
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 131
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 132
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 133
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 134
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 135
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 136
Suggested Citation:"Appendix C Possible Combinations of Scores." Institute of Medicine. 2002. Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment. Washington, DC: The National Academies Press. doi: 10.17226/10456.
×
Page 137
Next: Appendix D Table of Food and Drug Administration Actions on Dietary Supplements »
Proposed Framework for Evaluating the Safety of Dietary Supplements -- For Comment Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!